Genetic studies further support the pivotal involvement of IL-23 in disease pathogenesis, demonstrating that variants in the IL23R gene are significantly associated with susceptibility to inflammatory bowel disease (IBD). This evidence concerns the gene IL37 and inflammatory bowel disease.